NRX THERAPEUTICS INC (NRXP) Stock Earnings Estimates

USA • Nasdaq • NASDAQ:NRXP • US6294442099

2.1 USD
-0.02 (-0.94%)
At close: Jan 30, 2026
2.1062 USD
+0.01 (+0.3%)
After Hours: 1/30/2026, 8:09:30 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
NRXP revenue by date.NRXP revenue by date.
N/AN/A
847.91%		N/A
372.15%		N/A
106.43%		N/A
69.69%		N/A
8.59%		N/A
33.14%		N/A
0.37%		N/A
EBITDA
YoY % growth
NRXP ebitda by date.NRXP ebitda by date.
N/AN/AN/AN/A-94.428M-44.331M
53.05%		-27.582M
37.78%		-19.699M
28.58%		N/A
29.06%		N/A
165.69%		N/A
713.33%		N/A
171.44%		N/A
47.71%		N/A
33.42%		N/AN/AN/A
EBIT
YoY % growth
NRXP ebit by date.NRXP ebit by date.
-134.5K-1.007M
-648.33%		-713.2K
29.14%		-907.4K
-27.23%		-94.43M
-10,306.66%		-44.335M
53.05%		-27.587M
37.78%		-19.704M
28.58%		N/A
39.90%		N/A
553.28%		N/A
412.99%		N/A
120.13%		N/A
98.13%		N/A
5.25%		N/A
89.32%		N/A
1.71%		N/A
-0.25%
Operating Margin
NRXP operating margin by date.NRXP operating margin by date.
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
NRXP eps by date.NRXP eps by date.
N/AN/AN/AN/AN/AN/A-4.00
39.04%		-2.31
42.25%		N/A
32.59%		N/A
156.33%		N/A
284.88%		N/A
51.06%		N/A
9.80%		N/A
7.10%		N/AN/AN/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth		0.00
99.67%		-0.05
75.71%		0.01
103.29%		0.06
111.56%		0.12
4,700.00%
Revenue
Q2Q % growth		7.676M14.535M18.615M22.491M
9,193.80%		41.004M
434.18%
EBITDA
Q2Q % growth		-2.142M
40.98%		10.914M
391.27%		11.016M
395.34%		10.608M
359.36%		11.016M
614.29%
EBIT
Q2Q % growth		-9.435K
99.74%		-1.02M
72.78%		510K
113.67%		1.02M
124.77%		10.506M
111,451.35%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth		 -0.50
-284.62%		-0.09-0.41-476.70%
Q2 2025
Q2Q % growth		 -0.31
53.73%		-0.21-0.10-49.47%
Q1 2025
Q2Q % growth		 -0.21
71.62%		-0.310.1031.37%
Q4 2024
Q2Q % growth		 -0.77
-54.00%		-0.32-0.45-138.39%
Q3 2024
Q2Q % growth		 -0.13
81.43%		-0.650.5280.09%
Q2 2024
Q2Q % growth		 -0.67
44.17%		-0.710.045.49%
Q1 2024
Q2Q % growth		 -0.74
53.75%		-0.56-0.18-31.91%
Q4 2023
Q2Q % growth		 -0.50
68.75%		-0.710.2129.97%
Q3 2023
Q2Q % growth		 -0.70
50.00%		-1.160.4639.44%
Q2 2023
Q2Q % growth		 -1.20
-9.09%		-1.390.1913.92%
Q1 2023
Q2Q % growth		 -1.60
-661.90%		-1.43-0.17-12.04%
Q4 2022
Q2Q % growth		 -1.60
-1,677.78%		-1.48-0.12-8.18%
Q3 2022
Q2Q % growth		 -1.40
-250.00%		-1.430.031.96%
Q2 2022
Q2Q % growth		 -1.10
-189.47%		-1.02-0.08-7.84%
NRXP Yearly EPS VS EstimatesNRXP Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 2 -2 4 -4 -6
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth		 242K 6.962M-6.72M-96.52%
Q2 2025
Q2Q % growth		 1.53M-1.53M-100.00%
Q1 2025
Q2Q % growth		 1.16M-1.16M-100.00%
NRXP Yearly Revenue VS EstimatesNRXP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2025 2026 2027 2028 2029 2030 2031 2032 2033 500M 1B 1.5B 2B 2.5B
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS-200% -100.96% 3.38% -445.24%
Revenue-19.3% -49.83% -19.91% -54.75%